Alpha Dna Investment Management LLC Guardant Health, Inc. Transaction History
Alpha Dna Investment Management LLC
- $257 Million
- Q4 2024
Shares
2 transactions
Others Institutions Holding GH
# of Institutions
355Shares Held
115MCall Options Held
793KPut Options Held
1.85M-
Vanguard Group Inc Valley Forge, PA12.1MShares$528 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$492 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT6.42MShares$281 Million8.64% of portfolio
-
Baillie Gifford & CO5.45MShares$239 Million0.13% of portfolio
-
Cadian Capital Management, LP New York, NY5.22MShares$229 Million9.25% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $4.48B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...